A narrative review examined salvianolic acids A, B, and C for treating acute kidney injury, chronic kidney disease, nephrotic syndrome, and diabetic nephropathy. The study looked at how these compounds interact with kidney pathways and their potential to reduce fibrosis. No specific patient groups or sample sizes were reported because this is a review of existing data rather than a new trial. The authors noted that these acids have low oral bioavailability and are metabolized rapidly by the body. They also showed insufficient distribution within the kidney tissue to be effective on their own. Safety data were not reported in this review. The main reason to be careful is that these compounds may not reach kidney cells in high enough amounts to work well. Readers should understand that this information supports further translation into clinical therapies but does not yet prove they are ready for widespread use. More research is needed to confirm if these acids can effectively treat kidney disease in real-world settings.
Narrative review of salvianolic acids for kidney disease pharmacokinetics and anti-fibrotic activitySalvianolic Acids Show Potential for Kidney Disease Treatment
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider the preclinical pharmacokinetic and anti-fibrotic data on salvianolic acids for kidney disease, noting major bioavailability limitations.
This is a narrative review that synthesizes preclinical evidence on salvianolic acids A, B, and C for acute kidney injury, chronic kidney disease, nephrotic syndrome, and diabetic nephropathy. The scope covers pharmacokinetic parameters, including half-life, time to peak concentration, peak plasma concentration, and area under the curve, as well as efficacy intensity, target affinity, pathway specificity, renal distribution, and anti-fibrotic activity.
The authors qualitatively discuss the pharmacokinetic profile and potential mechanisms of these compounds. They note that salvianolic acids show activity in renal distribution and anti-fibrotic pathways, but the evidence is preclinical and observational.
Key limitations acknowledged by the authors include low oral bioavailability, rapid metabolism, and insufficient renal distribution. The review does not report specific study populations, sample sizes, or adverse event data.
The authors support further translation into clinical therapies but emphasize that long-term anti-fibrotic activity and chronic intervention effects are not established. Practice relevance is restrained due to the early and incomplete evidence base.
What this means for you:
Review suggests salvianolic acids need more study before clinical use for kidney disease. More on Chronic Kidney Disease
Cross-sectional study links declining nephron number to CKD stage in diabetic nephropathy
Kidney Filters Fail One by One in Diabetes
This cross-sectional observational study abstract examined 105 patients with biopsy-proven diabetic nephropathy and overt proteinuria, strat…
Even when kidneys look okay, their filters are quietly failing in people with diabetes, a new study shows — and that could explain why damag…
Finerenone reduces mortality and heart failure risk (HR 0.644) in post-AMI patients
Finerenone may lower heart failure risk after heart attack
This retrospective cohort study of 1,012 adult patients with AMI found that finerenone initiation within 6 months was associated with a lowe…
A new look at real-world data suggests the drug finerenone could protect hearts and kidneys in patients following a heart attack.
Post-translational modifications represent a critical target for precise molecular intervention in diabetic kidney disease
Protein modifications may drive diabetic kidney disease progression
This systematic review examines the role of post-translational modifications (PTMs) such as phosphorylation and acetylation in diabetic kidn…
A new review reveals how tiny protein changes fuel diabetic kidney disease, opening doors for targeted treatments.
Continuous renal replacement therapy may support metabolic and circulatory stability in preterm infants with AKI
CRRT Treatment Shows Promise for Infants with Kidney Injury
This case report and literature review describes the use of continuous renal replacement therapy (CRRT) for a very low birth weight preterm …
A new case report highlights how continuous renal replacement therapy may help stabilize very low birth weight infants facing acute kidney i…
View Original Abstract ↓
Kidney diseases, including acute kidney injury (AKI), chronic kidney disease (CKD), nephrotic syndrome (NS) and diabetic nephropathy (DN), represent a major global public health concern. Salvianolic acids are water-soluble bioactive components from Salvia miltiorrhiza, among which salvianolic acid A (SAA), salvianolic acid B (SAB) and salvianolic acid C (SAC) are the focus of current research. This review systematically elaborates their renoprotective value, establishes a clear pharmacokinetic-pharmacodynamic (PK-PD) correlation, summarizes multi-target protective effects in multiple kidney disease models, and conducts in-depth horizontal comparisons of efficacy intensity, target affinity and pathway specificity among the three components, key pharmacokinetic parameters including half-life (T1/2), time to peak concentration (Tmax), peak plasma concentration (Cmax), and area under the curve (AUC). Low oral bioavailability, rapid metabolism and insufficient renal distribution are common bottlenecks that restrict therapeutic efficacy, especially long-term anti-fibrotic activity and chronic intervention effects. Accordingly, promising strategies such as kidney-targeted nanodelivery systems and structural modification are proposed, and the mechanism of enhancing efficacy by optimizing pharmacokinetic properties is clarified. This review improves the mechanistic understanding of salvianolic acids, strengthens the horizontal comparison of three components, and supports their further translation into clinical therapies.
Mazdutide monotherapy reduces HbA1c and promotes weight loss in Chinese adults with type 2 diabetes over 48 weeks
New Drug Lowers Sugar and Shrinks Weight in Diabetes
Related in Drug Pipeline
Incretin-based therapies outperform placebo for glycemic control and weight loss in type 2 diabetes
Newer diabetes drugs outperform for blood sugar and weight loss
This network meta-analysis of 15 incretin-based therapies (IBTs) indicates that tirzepatide, orforglipron, and semaglutide provide superior …
A large analysis finds that newer incretin-based drugs like tirzepatide and semaglutide beat placebo for blood sugar and weight loss in type…
TCM decoctions combined with conventional treatment improve FEV1 and PEF in pediatric asthma
Traditional herbal decoctions may improve lung function in children with asthma
This network meta-analysis of randomized controlled trials evaluated TCM decoctions added to conventional biomedical treatment for pediatric…
New research suggests that adding specific traditional Chinese medicine decoctions to standard care can improve lung function for children w…
Curcumin reduces tumor weight and volume in preclinical models of breast cancer
Curcumin Shows Potential to Reduce Breast Cancer Tumors in Lab Models
This meta-analysis of preclinical animal models indicates that curcumin significantly reduces tumor weight (SMD -1.65) and volume (SMD -2.47…
Early laboratory studies show that curcumin may reduce tumor size and slow cell growth in breast cancer models, though more human research i…
Naringenin shows strong antidepressant-like effects in rat meta-analysis
Citrus compound shows antidepressant effects in rats
This meta-analysis of 13 preclinical studies (212 rats) found that naringenin significantly reduced immobility time in forced swimming and t…
A citrus compound called naringenin reduced depression-like behaviors in rats across 13 studies, but human trials are needed.
From Other Specialties
Aerobic and resistance exercise improve fatigue, physical function, and pain in systemic lupus erythematosus
Exercise Eases Fatigue and Pain in Lupus Patients
This meta-analysis of 470 adults with SLE found that aerobic, resistance, or combined exercise leads to small-to-moderate improvements in fa…
A review of 470 lupus patients finds exercise improves fatigue, pain, and mood without worsening disease activity.
Clinical decision rules significantly reduce radiography for pediatric ankle injuries in emergency department settings
Clinical rules can reduce unnecessary X-rays for children's limb injuries
This meta-analysis of 8 studies involving 7793 children found that clinical decision rules and guidelines can effectively reduce imaging for…
New data shows that using specific clinical decision rules can significantly cut down on the number of X-rays needed for children with limb …
GSTO1 inhibition induces apoptosis in AML cells while LMRS model stratifies patient risk
New lipid metabolism markers help predict outcomes for leukemia patients
This guideline synthesizes in vitro and observational data regarding lipid metabolism in acute myeloid leukemia (AML). The findings identify…
Researchers identified a new way to group and predict survival for patients with acute myeloid leukemia using lipid metabolism patterns.
Topical clobetasol resolves recalcitrant Pagetoid reticulosis in a single case report
Rare skin condition cleared with common steroid cream
This case report with literature review describes a 53-year-old woman with a 5-year history of a recalcitrant pruritic plaque on the right a…
A woman's stubborn eczema-like rash turned out to a rare skin cancer. A common steroid cream cleared it completely.